Dupont E - Search Results

1

Hemifacial spasm: magnetic resonance angiography.

Jespersen JH, Dupont E, Gelineck J, Lundorf E. Jespersen JH, et al. Among authors: dupont e. Acta Neurol Scand. 1996 Jan;93(1):35-8. doi: 10.1111/j.1600-0404.1996.tb00167.x. Acta Neurol Scand. 1996. PMID: 8825270

2

[Hemifacial spasms--clinical picture, diagnosis and treatment].

Jespersen JH, Dupont E, Gelineck J, Lundorf E. Jespersen JH, et al. Among authors: dupont e. Ugeskr Laeger. 1995 Jun 26;157(26):3766-9. Ugeskr Laeger. 1995. PMID: 7631454 Danish.

3

Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients.

Dupont E, Andersen A, Boas J, Boisen E, Borgmann R, Helgetveit AC, Kjaer MO, Kristensen TN, Mikkelsen B, Pakkenberg H, Presthus J, Stien R, Worm-Petersen J, Buch D. Dupont E, et al. Acta Neurol Scand. 1996 Jan;93(1):14-20. doi: 10.1111/j.1600-0404.1996.tb00163.x. Acta Neurol Scand. 1996. PMID: 8825266 Clinical Trial.

4

Selegiline and levodopa in early or moderately advanced Parkinson's disease: a double-blind controlled short- and long-term study.

Sivertsen B, Dupont E, Mikkelsen B, Mogensen P, Rasmussen C, Boesen F, Heinonen E. Sivertsen B, et al. Among authors: dupont e. Acta Neurol Scand Suppl. 1989;126:147-52. doi: 10.1111/j.1600-0404.1989.tb01794.x. Acta Neurol Scand Suppl. 1989. PMID: 2515720 Clinical Trial.

5

A controlled release form of madopar in parkinsonian patients with advanced disease and marked fluctuations in motor performance.

Jensen NO, Dupont E, Hansen E, Mikkelsen B, Mikkelsen BO. Jensen NO, et al. Among authors: dupont e. Acta Neurol Scand. 1988 May;77(5):422-5. doi: 10.1111/j.1600-0404.1988.tb05930.x. Acta Neurol Scand. 1988. PMID: 3046226 Clinical Trial.

6

Driving with Parkinson's disease. A controlled laboratory investigation.

Lings S, Dupont E. Lings S, et al. Among authors: dupont e. Acta Neurol Scand. 1992 Jul;86(1):33-9. doi: 10.1111/j.1600-0404.1992.tb08050.x. Acta Neurol Scand. 1992. PMID: 1519472

7

Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence.

Larsen JP, Dupont E, Tandberg E. Larsen JP, et al. Among authors: dupont e. Acta Neurol Scand. 1994 Apr;89(4):242-51. doi: 10.1111/j.1600-0404.1994.tb01674.x. Acta Neurol Scand. 1994. PMID: 8042440 Review.

8

Focal changes of oxygen consumption in cerebral cortex of patients with Parkinson's disease during subthalamic stimulation.

Vafaee MS, ØStergaard K, Sunde N, Gjedde A, Dupont E, Cumming P. Vafaee MS, et al. Among authors: dupont e. Neuroimage. 2004 Jun;22(2):966-74. doi: 10.1016/j.neuroimage.2004.02.019. Neuroimage. 2004. PMID: 15193628

9

Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations.

Østergaard K, Sunde N, Dupont E. Østergaard K, et al. Among authors: dupont e. Mov Disord. 2002 Jul;17(4):693-700. doi: 10.1002/mds.10188. Mov Disord. 2002. PMID: 12210858 Clinical Trial.

10

Glutathione peroxidase in early and advanced Parkinson's disease.

Johannsen P, Velander G, Mai J, Thorling EB, Dupont E. Johannsen P, et al. Among authors: dupont e. J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):679-82. doi: 10.1136/jnnp.54.8.679. J Neurol Neurosurg Psychiatry. 1991. PMID: 1940936 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters